taxifolin has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhivya, V; Elangovan, N; Jayaraj, RL; Kaphle, A; Manigandan, K; Manimaran, D | 1 |
1 other study(ies) available for taxifolin and Colonic Neoplasms
Article | Year |
---|---|
Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antioxidants; beta Catenin; Carcinogens; Colon; Colonic Neoplasms; Humans; Intestinal Mucosa; Ligands; Male; Mast Cells; Mice; Molecular Docking Simulation; Neoplasm Proteins; NF-E2-Related Factor 2; NF-kappa B; Quercetin; Random Allocation; Wnt Signaling Pathway | 2015 |